EDWARDS LIFESCIENCES CORP (EWL.DE) Stock Fundamental Analysis
FRA:EWL • US28176E1082
73.36 EUR
+2.42 (+3.41%)
Last: Feb 27, 2026, 07:00 PM
We assign a fundamental rating of 6 out of 10 to EWL. EWL was compared to 63 industry peers in the Health Care Equipment & Supplies industry. EWL has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. While showing a medium growth rate, EWL is valued expensive at the moment. With these ratings, EWL could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
- In the past year EWL was profitable.
- In the past year EWL had a positive cash flow from operations.
- Each year in the past 5 years EWL has been profitable.
- Of the past 5 years EWL 4 years had a positive operating cash flow.
1.2 Ratios
- EWL's Return On Assets of 10.31% is amongst the best of the industry. EWL outperforms 92.31% of its industry peers.
- EWL's Return On Equity of 13.40% is fine compared to the rest of the industry. EWL outperforms 78.46% of its industry peers.
- EWL's Return On Invested Capital of 12.09% is amongst the best of the industry. EWL outperforms 87.69% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 13.4% | ||
| ROIC | 12.09% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- EWL has a better Profit Margin (23.25%) than 93.85% of its industry peers.
- EWL's Profit Margin has been stable in the last couple of years.
- The Operating Margin of EWL (27.73%) is better than 96.92% of its industry peers.
- In the last couple of years the Operating Margin of EWL has declined.
- EWL has a better Gross Margin (78.19%) than 92.31% of its industry peers.
- EWL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.73% | ||
| PM (TTM) | 23.25% | ||
| GM | 78.19% |
OM growth 3Y-8.34%
OM growth 5Y-1.77%
PM growth 3Y-19.64%
PM growth 5Y-1.18%
GM growth 3Y-2.35%
GM growth 5Y0.69%
2. Health
2.1 Basic Checks
- EWL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- EWL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 12.60 indicates that EWL is not in any danger for bankruptcy at the moment.
- EWL's Altman-Z score of 12.60 is amongst the best of the industry. EWL outperforms 93.85% of its industry peers.
- The Debt to FCF ratio of EWL is 0.75, which is an excellent value as it means it would take EWL, only 0.75 years of fcf income to pay off all of its debts.
- EWL has a Debt to FCF ratio of 0.75. This is amongst the best in the industry. EWL outperforms 90.77% of its industry peers.
- EWL has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
- With an excellent Debt to Equity ratio value of 0.06, EWL belongs to the best of the industry, outperforming 84.62% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.75 | ||
| Altman-Z | 12.6 |
ROIC/WACC1.23
WACC9.86%
2.3 Liquidity
- A Current Ratio of 4.00 indicates that EWL has no problem at all paying its short term obligations.
- EWL has a Current ratio of 4.00. This is amongst the best in the industry. EWL outperforms 92.31% of its industry peers.
- A Quick Ratio of 3.29 indicates that EWL has no problem at all paying its short term obligations.
- EWL's Quick ratio of 3.29 is amongst the best of the industry. EWL outperforms 92.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4 | ||
| Quick Ratio | 3.29 |
3. Growth
3.1 Past
- EWL shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.29%.
- EWL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.67% yearly.
- EWL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.86%.
- EWL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.70% yearly.
EPS 1Y (TTM)-2.29%
EPS 3Y1.06%
EPS 5Y6.67%
EPS Q2Q%-1.69%
Revenue 1Y (TTM)10.86%
Revenue growth 3Y10.77%
Revenue growth 5Y6.7%
Sales Q2Q%13.26%
3.2 Future
- Based on estimates for the next years, EWL will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.79% on average per year.
- EWL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.72% yearly.
EPS Next Y16.14%
EPS Next 2Y13.34%
EPS Next 3Y13.01%
EPS Next 5Y12.79%
Revenue Next Year10.47%
Revenue Next 2Y10.14%
Revenue Next 3Y10.12%
Revenue Next 5Y9.72%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 33.81, which means the current valuation is very expensive for EWL.
- EWL's Price/Earnings ratio is in line with the industry average.
- The average S&P500 Price/Earnings ratio is at 27.07. EWL is valued slightly more expensive when compared to this.
- EWL is valuated quite expensively with a Price/Forward Earnings ratio of 29.13.
- EWL's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. EWL is more expensive than 66.15% of the companies in the same industry.
- EWL's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.05.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.81 | ||
| Fwd PE | 29.13 |
4.2 Price Multiples
- 66.15% of the companies in the same industry are cheaper than EWL, based on the Enterprise Value to EBITDA ratio.
- The rest of the industry has a similar Price/Free Cash Flow ratio as EWL.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 62.85 | ||
| EV/EBITDA | 25.64 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- The decent profitability rating of EWL may justify a higher PE ratio.
- A more expensive valuation may be justified as EWL's earnings are expected to grow with 13.01% in the coming years.
PEG (NY)2.1
PEG (5Y)5.07
EPS Next 2Y13.34%
EPS Next 3Y13.01%
5. Dividend
5.1 Amount
- No dividends for EWL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
FRA:EWL (2/27/2026, 7:00:00 PM)
73.36
+2.42 (+3.41%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-10 2026-02-10/amc
Earnings (Next)04-21 2026-04-21/amc
Inst Owners89.94%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap42.57B
Revenue(TTM)6.07B
Net Income(TTM)1.37B
Analysts79.53
Price Target81.61 (11.25%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.01%
Min EPS beat(2)4.4%
Max EPS beat(2)9.63%
EPS beat(4)4
Avg EPS beat(4)5.38%
Min EPS beat(4)3.4%
Max EPS beat(4)9.63%
EPS beat(8)5
Avg EPS beat(8)2.27%
EPS beat(12)6
Avg EPS beat(12)1.21%
EPS beat(16)7
Avg EPS beat(16)-0.18%
Revenue beat(2)1
Avg Revenue beat(2)0.37%
Min Revenue beat(2)-0.12%
Max Revenue beat(2)0.85%
Revenue beat(4)1
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-2.1%
Max Revenue beat(4)0.85%
Revenue beat(8)1
Avg Revenue beat(8)-2.7%
Revenue beat(12)2
Avg Revenue beat(12)-2.12%
Revenue beat(16)2
Avg Revenue beat(16)-2.48%
PT rev (1m)-3.53%
PT rev (3m)0.37%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.25%
EPS NY rev (1m)0.43%
EPS NY rev (3m)1.63%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.31%
Revenue NY rev (1m)0.67%
Revenue NY rev (3m)0.9%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.81 | ||
| Fwd PE | 29.13 | ||
| P/S | 8.54 | ||
| P/FCF | 62.85 | ||
| P/OCF | 49.42 | ||
| P/B | 4.92 | ||
| P/tB | 6.88 | ||
| EV/EBITDA | 25.64 |
EPS(TTM)2.17
EY2.96%
EPS(NY)2.52
Fwd EY3.43%
FCF(TTM)1.17
FCFY1.59%
OCF(TTM)1.48
OCFY2.02%
SpS8.59
BVpS14.9
TBVpS10.66
PEG (NY)2.1
PEG (5Y)5.07
Graham Number26.97
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 13.4% | ||
| ROCE | 13.97% | ||
| ROIC | 12.09% | ||
| ROICexc | 18.01% | ||
| ROICexgc | 28.58% | ||
| OM | 27.73% | ||
| PM (TTM) | 23.25% | ||
| GM | 78.19% | ||
| FCFM | 13.59% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-8.34%
OM growth 5Y-1.77%
PM growth 3Y-19.64%
PM growth 5Y-1.18%
GM growth 3Y-2.35%
GM growth 5Y0.69%
F-Score5
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.75 | ||
| Debt/EBITDA | 0.33 | ||
| Cap/Depr | 138.79% | ||
| Cap/Sales | 3.69% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 56.86% | ||
| Profit Quality | 58.45% | ||
| Current Ratio | 4 | ||
| Quick Ratio | 3.29 | ||
| Altman-Z | 12.6 |
F-Score5
WACC9.86%
ROIC/WACC1.23
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.29%
EPS 3Y1.06%
EPS 5Y6.67%
EPS Q2Q%-1.69%
EPS Next Y16.14%
EPS Next 2Y13.34%
EPS Next 3Y13.01%
EPS Next 5Y12.79%
Revenue 1Y (TTM)10.86%
Revenue growth 3Y10.77%
Revenue growth 5Y6.7%
Sales Q2Q%13.26%
Revenue Next Year10.47%
Revenue Next 2Y10.14%
Revenue Next 3Y10.12%
Revenue Next 5Y9.72%
EBIT growth 1Y4.68%
EBIT growth 3Y1.54%
EBIT growth 5Y4.82%
EBIT Next Year25.88%
EBIT Next 3Y16.1%
EBIT Next 5Y14.72%
FCF growth 1Y67.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.09%
OCF growth 3YN/A
OCF growth 5YN/A
EDWARDS LIFESCIENCES CORP / EWL.DE FAQ
Can you provide the ChartMill fundamental rating for EDWARDS LIFESCIENCES CORP?
ChartMill assigns a fundamental rating of 6 / 10 to EWL.DE.
What is the valuation status of EDWARDS LIFESCIENCES CORP (EWL.DE) stock?
ChartMill assigns a valuation rating of 2 / 10 to EDWARDS LIFESCIENCES CORP (EWL.DE). This can be considered as Overvalued.
What is the profitability of EWL stock?
EDWARDS LIFESCIENCES CORP (EWL.DE) has a profitability rating of 7 / 10.
What are the PE and PB ratios of EDWARDS LIFESCIENCES CORP (EWL.DE) stock?
The Price/Earnings (PE) ratio for EDWARDS LIFESCIENCES CORP (EWL.DE) is 33.81 and the Price/Book (PB) ratio is 4.92.